| Hilal Mahmood Fanasch, MD | |
|
4400 E Flamingo Ave Ste 130, Nampa, ID 83687-9203 | |
| (208) 205-0350 | |
| (208) 205-0356 |
| Full Name | Hilal Mahmood Fanasch |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 45 Years |
| Location | 4400 E Flamingo Ave Ste 130, Nampa, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295857720 | NPI | - | NPPES |
| 122170708 | Medicaid | TX |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center | Lubbock, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Alphonsus Regional Medical Center Inc | 3476462359 | 509 |
News Archive
Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013.
In a new study, researchers at Uppsala University have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic leukemia. This has awakened hopes that this analysis method could pave the way for important breakthroughs in immunotherapy research and treatment.
The risk of Sudden Infant Death Syndrome (SIDS) appears to increase when infants are swaddled while sleeping on their stomachs or sides, new research has found.
More than one billion people worldwide live with a physical or mental disability, with 80 percent of those people living in developing countries, according to the first world report on disability, published by the WHO and World Bank on Thursday, the Guardian reports.
› Verified 1 days ago
| Entity Name | Saint Alphonsus Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649357716 PECOS PAC ID: 3476462359 Enrollment ID: O20040204001036 |
News Archive
Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013.
In a new study, researchers at Uppsala University have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic leukemia. This has awakened hopes that this analysis method could pave the way for important breakthroughs in immunotherapy research and treatment.
The risk of Sudden Infant Death Syndrome (SIDS) appears to increase when infants are swaddled while sleeping on their stomachs or sides, new research has found.
More than one billion people worldwide live with a physical or mental disability, with 80 percent of those people living in developing countries, according to the first world report on disability, published by the WHO and World Bank on Thursday, the Guardian reports.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hilal Mahmood Fanasch, MD 7750 S Broadway, Littleton, CO 80122-2623 Ph: (303) 734-2090 | Hilal Mahmood Fanasch, MD 4400 E Flamingo Ave Ste 130, Nampa, ID 83687-9203 Ph: (208) 205-0350 |
News Archive
Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013.
In a new study, researchers at Uppsala University have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic leukemia. This has awakened hopes that this analysis method could pave the way for important breakthroughs in immunotherapy research and treatment.
The risk of Sudden Infant Death Syndrome (SIDS) appears to increase when infants are swaddled while sleeping on their stomachs or sides, new research has found.
More than one billion people worldwide live with a physical or mental disability, with 80 percent of those people living in developing countries, according to the first world report on disability, published by the WHO and World Bank on Thursday, the Guardian reports.
› Verified 1 days ago
Wesley David Pidcock, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4400 E Flamingo Ave Ste 200, Nampa, ID 83687 Phone: 208-302-2100 Fax: 208-302-2125 | |
Kenneth Wilhelm Jr., Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4400 E Flamingo Ave, Nampa, ID 83687 Phone: 208-288-4970 Fax: 208-288-4990 | |
Michael M Dee, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 215 E Hawaii Ave, Nampa, ID 83686 Phone: 208-463-3234 Fax: 208-463-3044 | |
Justin Tomal, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Garrity Blvd, Nampa, ID 83687 Phone: 208-343-6458 | |
Braden Lawrence, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 85 S Middleton Rd, Nampa, ID 83651 Phone: 208-381-4100 | |
Ryan J. Williams, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 900 N Happy Valley Rd, Nampa, ID 83687 Phone: 208-401-9639 | |
Nicholas W. Hodgman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4424 E Flamingo Ave, Ste 300, Nampa, ID 83687 Phone: 208-302-0200 Fax: 208-302-0255 |